Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

This trial is conducted in China. This trial aims for a comparison of the effect on glycemic control in subjects with type 2 diabetes of insulin detemir or NPH-insulin given once daily at bedtime as add-on to oral anti-diabetic drug(s).

Inclusion Criteria:

• Type 2 diabetes
• HbA1C greater than 7.5% and less than or equal to 11.0%
• Currently on any oral antidiabetic drug (OAD) more than or equal to 3 months

Exclusion Criteria:

• Previous acute treatment with insulin for more than 7 days.
• Treatment with OAD(s) which does not adhere to the approval labeling.
• Proliferate retinopathy or maculopathy that has required acute treatment within the last year.
• Known hypoglycaemia unawareness or recurrent major hypoglycaemia, that may interfere with study participation as judged by the Investigator.